SERTRALINE-25 25 MG
SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG · DIN 02241302 · PRO DOC LIMITEE
Health Canada status: MARKETED
What is SERTRALINE-25?
SERTRALINE-25 25 MG contains SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02241302, held by PRO DOC LIMITEE, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 20-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SERTRALINE-25 used for?
SERTRALINE is indicated for the symptomatic relief of depressive illness. It is also indicated for the symptomatic relief of panic disorder, with or without agoraphobia, and for the symptomatic relief of obsessive-compulsive disorder (OCD).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02241302 |
|---|---|
| Brand name | SERTRALINE-25 |
| Generic / active ingredient | SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 25 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AB06 SERTRALINE |
| AHFS class | 28:16.04.20 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Mar-2026 |
| Original market date | 2001-02-15 00:00:00 |
How is it stored and handled?
null
How is it supplied?
SERTRALINE 25 mg: Available in bottles of 100, unit dose packages of 30, 60 and 100. SERTRALINE 50 mg: Available in bottles of 100, 250 and 500, unit dose packages of 30, 60 and 100. SERTRALINE 100 mg: Available in bottles of 100, 250 and 500, unit dose packages of 30 and 100.
Is SERTRALINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N06AB06 SERTRALINE. 54 of 105 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-SERTRALINE | 100 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477904 |
| AG-SERTRALINE | 25 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477882 |
| AG-SERTRALINE | 50 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477890 |
| APO-SERTRALINE | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238282 |
| APO-SERTRALINE | 25 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238280 |
| APO-SERTRALINE | 50 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238281 |
| AURO-SERTRALINE | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390922 |
| AURO-SERTRALINE | 25 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390906 |
| AURO-SERTRALINE | 50 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390914 |
| BIO-SERTRALINE | 100 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02445069 |
Who else supplies SERTRALINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SERTRALINE appears in 4790 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.